G2b Biologics Private Limited - Company Profile

It is a life sciences private limited company based in Pune, Maharashtra, India, established in 2018.
2018 Pune, Maharashtra, India Active
Last Updated:
Access Report
About G2b Biologics Private Limited

G2b Biologics Private Limited, a active private limited company, was established on 13 March 2018 in Pune, Maharashtra, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U73200PN2018PTC175351. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Sureshkumar Ramasamy (Director), Deepanjan Ghosh (Director). Past directors included Harshavardhan Thirupathi. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Plot No 12, Sr No 651/1, Aai Mata Mandir Road, Near Datta Temple,, Pune, Maharashtra, 411037.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73200PN2018PTC175351

  • Registration Number

    175351

  • Incorporation Date

    13 March 2018

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 11 Months
  • Last Filing with ROC 31 Mar 2021
  • Revenue Growth **** -22.62%
  • Profit Growth **** -3088.71%
  • Ebitda **** 17.01%
  • Net Worth -178.48%
  • Total Assets -48.82%
Company report

G2b Biologics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into G2b Biologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at G2b Biologics Private Limited?
Current Directors
Name Designation Appointment Date Status
Sureshkumar Ramasamy Director 13 Mar 2018 Current
Deepanjan Ghosh Director 13 Mar 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of G2B Biologics.

G2B Biologics Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 22.62% decrease. The company also saw a substantial fall in profitability, with a 3088.71% decrease in profit. The company's net worth observed a substantial decline by a decrease of 178.48%.

G2B Biologics revenue growth over time
G2B Biologics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -22.62%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -48.82%
*******
*******
*******
*******
Profit or Loss
*******
 -3088.71%
*******
*******
*******
*******
Net Worth
*******
 -178.48%
*******
*******
*******
*******
EBITDA
*******
 17.01%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of G2B Biologics?

In 2021, G2B Biologics had a promoter holding of 99.75% and a public holding of 0.25%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at G2B Biologics?

Unlock and access historical data on people associated with G2B Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of G2B Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G2B Biologics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on G2B Biologics
Recent Activity within the Organization
  • Annual General Meeting

    Progress on G2B Biologics Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was documented.

  • Balance Sheet

    The activity G2B Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Pune. was completed.

  • Director Appointment

    Sureshkumar Ramasamy was appointed as a Director was appointed as a Director on 13 Mar 2018 & has been associated with this company since 7 years 11 months . was recorded as a recent event.

  • Director Appointment

    The activity Deepanjan Ghosh was appointed as a Director was appointed as a Director on 13 Mar 2018 & has been associated with this company since 7 years 11 months . was completed.

  • Company Incorporation

    G2B Biologics Private Limited was registered on 13 Mar 2018 with Roc Pune & aged 7 years 11 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of G2b Biologics Private Limited?

The CIN of G2b Biologics Private Limited is U73200PN2018PTC175351.

Where is G2b Biologics Private Limited headquartered?

G2b Biologics Private Limited is headquartered at Plot No 12, Sr No 651/1, Aai Mata Mandir Road, Near Datta Temple,, Pune, Maharashtra, 411037.

When was G2b Biologics Private Limited incorporated?

G2b Biologics Private Limited was incorporated on 13 March 2018.

Who are the current directors of G2b Biologics Private Limited?

The current directors of G2b Biologics Private Limited are

What is the primary industry of G2b Biologics Private Limited?

The primary industry of G2b Biologics Private Limited is Professional, Scientific And Technical.

Is G2b Biologics Private Limited a listed company?

G2b Biologics Private Limited is unlisted.

What is the capital structure of G2b Biologics Private Limited?

The authorized capital of G2b Biologics Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available